In the present study, we analyzed CD16 and CD56 double positive NK cells in the healthy and different stages of CRC patients before initial treatment, trying to figure out the value of CD16+CD56+ NK cells in the prediction and pretreatment staging of CRC. Here, NCAM1 is linked to colorectal carcinoma.